Whole-genome methylation profiling of menstrual stem cells identifies novel biomarkers for endometriosis
This study analyzed whole-genome DNA methylation in menstrual stem cells to identify novel biomarkers associated with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study aimed to identify endometriosis-related biomarkers by performing whole-genome DNA methylation profiling on menstrual blood-derived mesenchymal stem cells (MenSCs), using accompanying bioinformatics analysis scripts. The investigators generated methylation data from these cells and focused the downstream analysis on discovering candidate methylation markers associated with endometriosis. A key limitation noted in the repository context is that this publication primarily provides the analysis scripts for methylation profiling rather than a full clinical validation workflow or experimental details within the text provided. This paper is centrally about endometriosis — it uses whole-genome methylation profiling of menstrual stem cells to discover novel endometriosis biomarkers.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00